摘要
[目的]观察胃黏膜脱垂（GMP）的内镜下检出率及康复新液治疗GMP的临床疗效。[方法]2008年8月20日-11月18日于空军总医院行胃镜检查的1 000例患者,观察并总结GMP的胃镜下检出率。对检出的GMP患者进行临床症状及内镜下炎症评分,并按奇偶数分为2组,治疗组给予康复新液10 ml,3次/d口服;对照组给予硫糖铝混悬液10 ml,3次/d口服,随访观察3个月后复查胃镜。[结果]GMP内镜下检出率为20.4%。治疗组消化不良症状总积分降低率为（64.89±7.88）%,对照组为（40.71±10.67）%（P〈0.01）。治疗组治疗后内镜下炎症积分均数从治疗前的4.037下降至1.336（P〈0.01）,与对照组比较差异有统计学意义（P〈0.01）。[结论]GMP内镜下检出率较高;康复新液对GMP消化不良症状和内镜表现的改善优于硫糖铝混悬液。
[Objective]To observe the endoscopic detection rate and therapeutic effection of Kang-fuxin solution of gastric mucosa prolapsus.[Methods]One thousand patients who underwent gastroscopy in General Airforce Hospital from August 20th 2008 to November 18th 2009 were included.The endoscopic detection rate was observed and summarized.Grading of those patients were evaluated according to clinical symptom and inflammation observed under endoscopy.The patients were divided into therapeutic and control group odevity.Kangfuxin 10ml,tid,was administed to therapeutic group,Sucralfate Suspension 10ml,tid,was administed to control group.[Results]The endoscopic detection rate of gastric mucosa prolapsus was 20.4%.The average degrading percentage of total integral of dyspepsia symptom was（64.89±7.88）% in therapeutic group,and was（40.71±10.67）% in control group（P〈0.01）.Significant effection was observed in therapeutic group,common effection was observed in control group.The average grading of inflammation observed in endoscopy decreased from 4.037 before therapy to 1.336 after therapy in therapeutic group（P〈0.01）,and statistical significance was also existed compared to control group（P〈0.01）.[Conclusion]The endoscopic detection rate of gastric mucosa prolapsus is fairly high.The therapeutic effection of Kang-fuxin solution is better than Sucralfate Suspension to improve dyspepsia symptom and endoscopic expression of gastric mucosa prolapsus.
出处
《中国中西医结合消化杂志》
CAS
2010年第1期27-29,共3页
Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词
胃黏膜脱垂
内窥镜术
康复新液
gastric mucosa prolapsus
detection rate
Kang-fuxin solution
